We are delighted to congratulate Prof. Rami Aqeilan on receiving a $2 million SPARK NS grant to advance a novel gene therapy program for SHINE syndrome, intending to submit an IND application to the FDA within the next two years.
Congratulations on this outstanding achievement!
